Sponsored by Angelini Pharma 15 Oct 2024 The future of epilepsy treatment: pioneering advances and patient-centric care Epilepsy, one of the most widespread neurological diseases in the world, characterized by recurrent seizures, affects approximately 50 million people globally. In Europe, up to six million people are estimated to be living with the disease. Whilst treatment options have come a long way over the last few decades, clinical practice still shows significant unmet […] October 15, 2024 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 3 Oct 2024 Six biotechs driving progress in Duchenne muscular dystrophy In this article, we take a look at six clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space. October 3, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 16 Sep 2024 Vironexis’ AAV vector approach: The next frontier in cancer immunology? Delve into Vironexis’ launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform. September 16, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 9 Aug 2024 The therapeutic potential of circular RNA: Could it soon trump mRNA technology? Find out about circular RNA, an emerging technology that could hold a lot of promise for next-generation vaccines and gene therapies. August 9, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 1 Jul 2024 Special Olympics: How is biotechnology revolutionizing sports performance worldwide? Find out about biotechnology’s impact on sports performance and recovery, from genetic profiling, stem cells, and wearable technologies. July 1, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Sponsored by Cryoport Systems 18 Jun 2024 Overcoming obstacles as advanced therapies continue to evolve in Europe Discover strategies to overcome the challenges in advanced therapy development in Europe’s evolving biopharmaceutical landscape. June 18, 2024 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 May 2024 Eight companies spearheading Philadelphia’s biotech industry Often called the Cellicon Valley due to its focus on cell and gene therapy, discover eight Philadelphia biotech companies to know about. May 21, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 3 May 2024Can emerging new treatments lead the way to cure Duchenne muscular dystrophy? Delve into the new treatment approaches to Duchenne muscular dystrophy, a challenging disease for those suffering from it, and research. May 3, 2024 Share WhatsApp Twitter Linkedin Email
In Depth 2 May 2024 New treatments for cystic fibrosis: boosting life expectancy Discover how cystic fibrosis treatments are extending life expectancy, with recent advancements set to increase it by 75% by next year. May 2, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 29 Apr 2024 Can Brazil make cell and gene therapy costs affordable for all? Found out how Brazil is attempting to make gene and cell therapy costs affordable for all with a new initiative. April 29, 2024 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Apr 2024 8 of the most expensive drugs in biopharma: Unraveling the costliest medications Find out what the eight most expensive drugs in the world currently are, as several gene therapies top the list. April 25, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 14 Mar 2024 Rett syndrome: advances in gene therapy brings hope Explore the latest advancements in treating Rett syndrome, a rare genetic disorder, including groundbreaking gene therapies and drug trials. March 14, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email